| Financial Year |
March 31 2023 |
| Monetary Funds |
316,671,854.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
134,845,034.09 |
| Advances to Suppliers |
3,484,881.05 |
| Other Receivables |
43,649,814.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
97,966,065.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,529,920.07 |
| Total Current Assets |
635,227,276.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
19,032,259.74 |
| Long-term Equity Investment |
789,996.24 |
| Investment Properties |
70,298,604.51 |
| Fixed Assetes |
694,365,487.40 |
| Under-construction Projects |
149,689,559.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
300,566,934.21 |
| R&D expenses |
8,560,013.10 |
| Goodwill |
6,471,327.38 |
| Long-Term Deferred and Prepaid Expenses |
3,234,674.13 |
| Deferred Income Tax Assets |
12,681,203.92 |
| Other Non-Current Assets |
17,220,728.84 |
| Sub-Total of Non-Current Assets |
1,862,612,128.07 |
| Total Assets |
2,497,839,404.70 |
| Short-Term Loans |
60,714,159.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
80,644,630.35 |
| Accounts Payable |
341,353,685.94 |
| Accounts Received In Advance |
394,315.72 |
| Employee Compensation Payable |
14,651,017.08 |
| Taxes Payable |
101,068,089.03 |
| Interest Payable |
-- |
| Dividend Payable |
9,260,010.27 |
| Other payables |
562,790,744.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,500,180.25 |
| Other Current Liabilities |
1,447,277.63 |
| Sub-Total of Current Liabilities |
1,201,708,567.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
101,286,548.62 |
| Total Liabilities |
1,302,995,115.88 |
| Paid-In Capital(Or Share Stock) |
1,752,424,858.00 |
| Capital Surplus |
4,912,419,603.72 |
| Surplus Reserve |
87,142,242.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,581,393,527.38 |
| Minority Stockholder's Interest |
166,935,115.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,027,909,173.21 |
| Owner's Equity（Stockholder's Equity） |
1,194,844,288.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,497,839,404.70 |
